| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/26/2000 | EP0974058A2 20 human secreted proteins |
| 01/26/2000 | EP0974057A1 Methods to detect hk2 polypeptides |
| 01/26/2000 | EP0973945A1 Chiral peptide nucleic acids and methods for preparing same |
| 01/26/2000 | EP0973944A1 Reagents and methods useful for detecting diseases of the gastrointestinal tract |
| 01/26/2000 | EP0973935A2 Target genes for allele-specific drugs |
| 01/26/2000 | EP0973934A1 Transgenically produced non-secreted proteins |
| 01/26/2000 | EP0973933A1 Immunological tolerance to hiv epitopes |
| 01/26/2000 | EP0973927A1 Chimeric adenoviral coat protein and methods of using same |
| 01/26/2000 | EP0973926A1 Adenoviral vectors with modified tropism |
| 01/26/2000 | EP0973925A2 Matrix derived anti-hiv peptides and transdominant proteins |
| 01/26/2000 | EP0973923A1 IMPROVED ASSAYS FOR $g(b)-AMYLOID PROCESSING |
| 01/26/2000 | EP0973922A2 Strawberry fruit promoters for gene expression |
| 01/26/2000 | EP0973920A1 An oleosin 5' regulatory region for the modification of plant seed lipid composition |
| 01/26/2000 | EP0973911A1 MUTANT $i(msbB) or $i(htrB) GENES |
| 01/26/2000 | EP0973910A1 Bacillus thuringiensis toxins |
| 01/26/2000 | EP0973909A2 Process for extracting and purifying recombinant, non-lipidised osp-protein |
| 01/26/2000 | EP0973908A2 Plants with controlled side-shoot formation and/or controlled abscission area formation |
| 01/26/2000 | EP0973907A1 Control of floral induction in plants and uses therefor |
| 01/26/2000 | EP0973906A1 Strawberry promoters and genes |
| 01/26/2000 | EP0973904A1 COMPOSITIONS AND USE OF M-CSF-alpha |
| 01/26/2000 | EP0973903A2 Protein for inhibiting apoptosis |
| 01/26/2000 | EP0973902A1 Radioisotope concentrator methods and compositions |
| 01/26/2000 | EP0973901A2 Flip gene and flip protein |
| 01/26/2000 | EP0973900A1 flt3 LIGAND CHIMERIC PROTEINS |
| 01/26/2000 | EP0973899A2 SECRETED EXPRESSED SEQUENCE TAGS (sESTs) |
| 01/26/2000 | EP0973898A2 SECRETED EXPRESSED SEQUENCE TAGS (sESTs) |
| 01/26/2000 | EP0973897A1 Human tumor-associated membrane protein |
| 01/26/2000 | EP0973896A2 SECRETED EXPRESSED SEQUENCE TAGS (sESTs) |
| 01/26/2000 | EP0973895A1 Transcription factor islet-brain 1 (ib1) |
| 01/26/2000 | EP0973894A1 Renal nuclear matrix proteins, polynucleotide sequences encoding them, and their use |
| 01/26/2000 | EP0973892A2 28 human secreted proteins |
| 01/26/2000 | EP0973891A1 Human chemokine receptor-like chemokine |
| 01/26/2000 | EP0973890A2 Secreted proteins and polynucleotides encoding them |
| 01/26/2000 | EP0973889A1 Human calcium channels alfa1 subunits and related probes, cell lines and methods |
| 01/26/2000 | EP0973888A1 Dendritic cell-derived growth factor |
| 01/26/2000 | EP0973887A1 Porcine leptin protein, nucleic acid sequences coding therefor and uses thereof |
| 01/26/2000 | EP0973879A2 Coxsackie virus vectors for delivery of nucleic acids encoding antigenic or therapeutic products |
| 01/26/2000 | EP0973878A1 Controlled dissolution cross-linked protein crystals |
| 01/26/2000 | EP0973806A1 Site protected protein modification |
| 01/26/2000 | EP0973805A1 Method for production of antibodies to specific sites of rapamycin |
| 01/26/2000 | EP0973803A1 Peptides useful for reducing symptoms of toxic shock syndrome |
| 01/26/2000 | EP0973802A1 Synthetic peptides useful in biological assays for detecting infections caused by group o hiv-1 viruses |
| 01/26/2000 | EP0973800A1 Novel receptor |
| 01/26/2000 | EP0973799A1 Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation |
| 01/26/2000 | EP0973797A1 Peptide compositions which induce immune tolerance and methods of use |
| 01/26/2000 | EP0973794A1 Netrin receptors |
| 01/26/2000 | EP0973547A1 Improving binding affinity of antigenic peptides for mhc molecules |
| 01/26/2000 | EP0973546A2 Stabilized human papillomavirus formulations |
| 01/26/2000 | EP0973545A1 Leishmania vaccine |
| 01/26/2000 | EP0973541A1 Therapeutic, prophylactic and diagnostic agent for cancer, useful for characterising cancer cells with individual properties |
| 01/26/2000 | EP0973540A1 Isolation and structural elucidation of the cytostatic linear and cyclo-depsipeptides dolastatin 16, dolastatin 17, and dolastatin 18 |
| 01/26/2000 | EP0973538A1 Modified proteins which bind extracellular matrix components |
| 01/26/2000 | EP0973536A1 Restenosis/atherosclerosis diagnosis, prophylaxis and therapy |
| 01/26/2000 | EP0973535A1 Protein crystals, their preparation and use |
| 01/26/2000 | EP0973530A1 Serum-derived factor inducing cell differentiation and medical uses thereof |
| 01/26/2000 | EP0973394A1 NUCLEIC ACID AND AMINO ACID SEQUENCES RELATING TO $i(HELICOBACTER PYLORI) AND VACCINE COMPOSITIONS THEREOF |
| 01/26/2000 | EP0973391A1 Endoderm, cardiac and neural inducing factors |
| 01/26/2000 | EP0973381A2 Animal model for evaluation of vaccines |
| 01/26/2000 | EP0871705A4 Human ccn-like growth factor |
| 01/26/2000 | EP0800649A4 Inhibition of glial cell proliferation |
| 01/26/2000 | EP0799305A4 Transgenic animal lacking native amyloid precursor protein |
| 01/26/2000 | EP0587735B1 T cell receptor peptides as therapeutics for immune-related disease |
| 01/26/2000 | EP0470974B1 Lytic peptides, use for growth, infection and cancer |
| 01/26/2000 | CN1242802A Notch protein and their ligands |
| 01/26/2000 | CN1242707A Use of GLP-1 analogs and derivatives administered peripherally in regulation of obesity |
| 01/26/2000 | CN1242376A Human nervous specific expression gene |
| 01/26/2000 | CN1242375A Method for directly and simply extracting FI protein from plant leaves |
| 01/26/2000 | CN1048731C Polynucleotide of drug binding protein as coded CSAID |
| 01/25/2000 | US6018106 Use of yeast poly (A) binding proteins and their genes for broad range protection of plants against bacterial, fungal and viral pathogens |
| 01/25/2000 | US6018104 Nucleic acid promoter fragment isolated from a plant tryptophan synthase alpha subunit (trpA) gene |
| 01/25/2000 | US6018102 A recombinant dna molecule encoding a stabilized protein; where the dna is capable of replication but not expression in a prokaryotic cell and is capable of expression in eukaryotic cell; fungicides, viricides, bactericides, antiprotozoa agent |
| 01/25/2000 | US6018100 A full length transcript promoter from a figwort mosaic virus; production of transgenic plants |
| 01/25/2000 | US6018099 A transgenic corn plant containing a chimeric gene which comprises a promoter sequence that directs transcription in roots; genetic engineering |
| 01/25/2000 | US6018097 Transgenic mice expressing human insulin |
| 01/25/2000 | US6018040 Fish insulin-like growth factor 11 promoter |
| 01/25/2000 | US6018039 A recombinant nucleotide sequence with an exogenous gene coding region is inserted at a targeted position; for producing transgenic animals for the expression of a desired substance in the mammary gland or tissue of an animal |
| 01/25/2000 | US6018038 Incompatible plant and pathogen interaction related gene |
| 01/25/2000 | US6018037 A recombinant dna coding for a peptide containing leucine instead of the usual 13th amino acid methionine; production of motilin; therapuetic applications |
| 01/25/2000 | US6018036 A nucleic acid molecule; therapy and diagnosis of systemic lupus erythematosis, leishmaniasis, myasthenia gravis, skin disorders; antidiabetic/antiarthritic/antiprotozia agents; parasiticides |
| 01/25/2000 | US6018032 A monoclonal antibody capable of binding to an epitope and neutralizing interleukin receptor; diagnosis and therapy for chronic bronchial asthma; antiasthmatic agent |
| 01/25/2000 | US6018030 Recombinant proteins that contain at least 50 percent of amino acids of naturally occuring repeating sequences; genetic engineering of structural components of prosthetic devices and synthetic fibers |
| 01/25/2000 | US6018029 DNA encoding canine interleukin-1 receptor antagonist |
| 01/25/2000 | US6018027 A polypeptide encoding a nucleic acid having morphology of herpes virus and a double stranded dna genome designated as a new human b lymphotropic virus; diagnosis and therapy |
| 01/25/2000 | US6018026 For rapid, inexpensive and adaptable high volume screening of ligands to receptors; for determining the presence of cell growth factors in samples; for purifying cell growth factors and isoforms |
| 01/25/2000 | US6018025 Compositions and methods for the treatment and diagnosis of cardiovascular disease using rchd528 as a target |
| 01/25/2000 | US6018024 A soluble fragment of amyloid protein having the carboxy terminal methionine or leucine amino acid resulting from cleavage of the intact protein; diagnosis and therapy for alzheimer's disease |
| 01/25/2000 | US6018023 Kainate-binding, human CNS receptors of the EAA3 family |
| 01/25/2000 | US6018022 Modification of pertussis toxin |
| 01/25/2000 | US6018019 Immunogenic synthetic peptides which are useful alone or in conjugates in vaccines against hemophilus influenza infection |
| 01/25/2000 | US6017943 Intramolecularly crosslinking hemoglobin to form a synthetic blood |
| 01/25/2000 | US6017897 Nucleic acid respiratory syncytial virus vaccines |
| 01/25/2000 | US6017885 IGF/IGFBP complex for promoting bone formation and for regulating bone remodeling |
| 01/25/2000 | US6017884 Method for treating acute hepatic failure |
| 01/25/2000 | US6017883 Composition and methods for the inhibition of phagocytes |
| 01/25/2000 | US6017880 Inhibition of retrovirus infection |
| 01/25/2000 | US6017879 Template associated NPY Y2-receptor agonists |
| 01/25/2000 | US6017878 Nerve growth factor structural analogs and their uses |
| 01/25/2000 | US6017877 Method and composition for treating thrombosis |
| 01/25/2000 | US6017876 Monosuccinylated exclusively a n-terminus |
| 01/25/2000 | US6017759 Chimeric infectious bursal disease virus cDNA clones, expression products and vaccines based thereon |